<< Prev  3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Next >>

Novartis Resubmits Inclisiran NDA 07/08/2021

Quidel Lyra Covid Assay Recall for False Negative Risk is Class 1: FDA 07/08/2021

AliveCor Gains Clearance for QTc Measurer 07/08/2021

Catalyst Wants Specific Tests for Some Amifampridine NDAs 07/08/2021

Regulatory Review Period for Beovu 07/07/2021

Regulatory Review Period for Barhemsys 07/07/2021

Guide on Unique Device Identifier Info 07/07/2021

Regulatory Review Period for Zephyr Valve Implant 07/07/2021

Porter Wants OIG Probe of Company Influence on FDA 07/07/2021

Athenex Evaluating New Cancer Drug Trial 07/07/2021

<< Prev  3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  Next >>